Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 28, 2021

SELL
$34.54 - $47.25 $174,012 - $238,045
-5,038 Closed
0 $0
Q1 2021

Dec 01, 2022

BUY
$42.51 - $63.78 $214,165 - $321,323
5,038 New
5,038 $227,000
Q4 2020

Dec 01, 2022

BUY
$45.3 - $60.27 $228,221 - $303,640
5,038 New
5,038 $285,000
Q1 2020

Apr 30, 2020

SELL
$41.6 - $63.4 $268,777 - $409,627
-6,461 Reduced 56.19%
5,038 $238,000
Q4 2019

Feb 06, 2020

SELL
$53.85 - $65.27 $51,696 - $62,659
-960 Reduced 7.71%
11,499 $693,000
Q3 2019

Oct 17, 2019

BUY
$59.06 - $72.15 $173,990 - $212,553
2,946 Added 30.97%
12,459 $747,000
Q2 2019

Jul 19, 2019

BUY
$62.09 - $86.14 $590,662 - $819,449
9,513 New
9,513 $612,000

Others Institutions Holding IONS

About IONIS PHARMACEUTICALS INC


  • Ticker IONS
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 141,940,992
  • Market Cap $4.83B
  • Description
  • Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an injection for the treatment of polyneuropathy of hereditary transthyretin-mediated amyloidosis in adults; and WAYLIVRA, a treatment for famil...
More about IONS
Track This Portfolio

Track Robeco Institutional Asset Management B.V. Portfolio

Follow Robeco Institutional Asset Management B.V. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Robeco Institutional Asset Management B.V., based on Form 13F filings with the SEC.

News

Stay updated on Robeco Institutional Asset Management B.V. with notifications on news.